Skip to main content
Zhaoke Ophthalmology Limited logo

Zhaoke Ophthalmology Limited — Investor Relations & Filings

Ticker · 6622 ISIN · KYG989M51017 LEI · 254900BGVNT5U0ZZR134 HKEX Manufacturing
Open in API
Filings indexed 251 across all filing types
Latest filing 2026-05-15 Declaration of Voting R…
Country KY Cayman Islands
Listing HKEX 6622

About Zhaoke Ophthalmology Limited

http://www.zkoph.com

Zhaoke Ophthalmology Limited is a leading ophthalmic pharmaceutical company established in 2017. Its core activities encompass the research, development, manufacturing, and commercialization of therapies designed to address significant global medical needs in vision health. The company maintains a comprehensive drug portfolio, featuring both innovative and generic treatments, which targets six major ophthalmic indications affecting the anterior and posterior segments of the eye, such as dry eye disease, myopia, and wet age-related macular degeneration (wAMD). Utilizing advanced, fully operational production facilities, Zhaoke is focused on accelerating product commercialization and collaborating with domestic and international partners to achieve its goal of becoming a world leader in ophthalmology.

Recent filings

Filing Released Lang Actions
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MAY 15, 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an official announcement of poll results from the company’s Annual General Meeting, listing vote counts for each proposed resolution. This fits the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2026-05-15 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026
Regulatory Filings
2026-05-05 English
CONTINUING CONNECTED TRANSACTIONS IN RELATION TO RENEWAL OF MASTER CMO SERVICE AGREEMENT
Regulatory Filings Classification · 95% confidence The document is an announcement from Zhaoke Ophthalmology Limited regarding the renewal of a Master CMO Service Agreement, which is a continuing connected transaction under the Hong Kong Listing Rules. It details the terms of the renewal, annual caps, historical transaction amounts, internal control measures, and implications under the Listing Rules. The document is structured as a formal announcement with no financial statements or detailed financial performance data. It focuses on contractual and regulatory disclosure related to connected transactions, which is typical for regulatory announcements about continuing connected transactions. It is not an annual report, interim report, earnings release, or any form of financial statement. It is also not a proxy statement, voting results, or management change announcement. The content fits the category of a Regulatory Filing (RNS) as it is a regulatory announcement required by the stock exchange rules about connected transactions and related compliance matters.
2026-04-30 English
NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM
Report Publication Announcement Classification · 92% confidence The document is a notification letter informing shareholders that the company’s Annual Report and Circular have been published electronically and providing instructions for obtaining printed copies. It does not contain the report itself but serves to announce and guide access to the published reports. This clearly fits the definition of a Report Publication Announcement (RPA).
2026-04-23 English
NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM
Report Publication Announcement Classification · 85% confidence The document is a notification letter informing shareholders that the Company’s annual report, circular and proxy form (collectively referred to as corporate communications) have been published on the HKEXnews and the Company’s website and providing instructions for electronic dissemination and request for printed copies. It does not contain the actual report content itself but simply announces its publication and access arrangements. Under the “menu vs meal” rule, this is a Report Publication Announcement rather than the report itself.
2026-04-23 English
FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, MAY 15, 2026
Proxy Solicitation & Information Statement Classification · 89% confidence The document is a ‘Form of Proxy’ for the Annual General Meeting, used to solicit shareholder votes ahead of the meeting. It is part of the proxy solicitation materials sent to shareholders to request voting instructions, which fits the definition of a Proxy Solicitation & Information Statement.
2026-04-23 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.